Abstract
Neonatal lupus erythematosus is an uncommon syndrome, which is caused by transplacental passage of maternal autoantibodies to Sjögren’s syndrome A or B autoantigens. The clinical presentation includes distinctive cutaneous lesions resembling those seen in systemic lupus erythematosus, hepatobiliary disease, and cytopenias, which disappear with the clearance of maternal autoantibodies. The most severe presentation is a total atrioventricular heart block, which begins during the second trimester of gestation and is irreversible. The risk of having a child with neonatal lupus erythematosus in mothers who test positive for autoantibodies to Sjögren’s syndrome autoantigens is approximately 2% for first pregnancies or if previous babies were healthy. The risk increases by approximately tenfold if a previous child had neonatal lupus erythematosus syndrome. The diagnosis of neonatal lupus erythematosus is made when the mother has autoantibodies to Sjögren’s syndrome autoantigens, and the fetus or newborn develops atrioventricular heart block, or the newborn develops the typical rash or hepatic or hematologic manifestations in the absence of other explanation. Fetal echocardiography from the 16th to the 26th week of gestation is advised in mothers with autoantibodies to Sjögren autoantigens. The detection of a slow fetal heart rate or the postnatal diagnosis of atrioventricular heart block warrants immediate maternal testing for these autoantibodies if not previously tested.
Similar content being viewed by others
References
Holt PG, Jones CA (2000) The development of the immune system during pregnancy and early life. Allergy 55:688–697
Ygberg S, Nilsson A (2012) The developing immune system—from foetus to toddler. Acta Paediatr 101:120–127
Giacoia GP (1992) Transplacentally transmitted autoimmune disorders of the fetus and newborn: pathogenic considerations. South Med J 85:139–145
Hoftman AC, Hernandez MI, Lee KW, Stiehm ER (2008) Newborn illnesses caused by transplacental antibodies. Adv Pediatr Infect Dis 55:271–304
Zhao CY, Chiang YZ, Murrell DF (2016) Neonatal autoimmune blistering disease: a systematic review. Pediatr Dermatol 33:367–374
Brucato A, Cimaz R, Stramba-Badiale M (2002) Neonatal lupus. Clin Rev Allergy Immunol 23:279–299
Bridge RG, Foley FE (1954) Placental transmission of the lupus erythematosus factor. Am J Med Sci 227:1–8
McCuistion CH, Schoch EP Jr (1954) Possible discoid lupus erythematosus in newborn infant; report of a case with subsequent development of acute systemic lupus erythematosus in mother. JAMA Dermatol 70:782–785
Hogg GR (1957) Congenital, acute lupus erythematosus associated with subendocardial fibroelastosis; report of a case. Am J Clin Pathol 28:648–654
Seip M (1960) Systemic lupus erythematosus in pregnancy with haemolytic anaemia, leucopenia and thrombocytopenia in the mother and her newborn infant. Arch Dis Child 35:364–366
Draznin TH, Esterly NB, Furey NL, DeBofsky H (1979) Neonatal lupus erythematosus. J Am Acad Dermatol 1:437–442
Anaya JM, Rojas-Villarraga A, Mantilla RD, Arcos-Burgos M, Sarmiento-Monroy JC (2016) Polyautoimmunity in Sjögren syndrome. Rheum Dis Clin N Am 42:457–472
Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, Ramos-Casals M (2016) Sjögren syndrome. Nat Rev Dis Primers 2:16047
Pisetsky DS (2017) Antinuclear antibody testing—misunderstood or misbegotten? Nat Rev Rheumatol 13:495–502
Buyon JP, Clancy RM (2005) Neonatal lupus: basic research and clinical perspectives. Rheum Dis Clin N Am 31:299–313
Lee LA (2009) The clinical spectrum of neonatal lupus. Arch Dermatol Res 301:107–110
Marks SD, Tullus K (2012) Autoantibodies in systemic lupus erythematosus. Pediatr Nephrol 27:1855–1868
Mavragani CP, Moutsopoulos HM (2014) Sjögren syndrome. CMAJ 186:E579–E586
Schett G (2017) Autoimmunity as a trigger for structural bone damage in rheumatoid arthritis. Mod Rheumatol 27:193–197
Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, Jusko TA, Walker NJ, Germolec DR, Whitt IZ, Crockett PW, Pauley BA, Chan JY, Ross SJ, Birnbaum LS, Zeldin DC, Miller FW (2012) Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 64:2319–2327
Rivera TL, Izmirly PM, Birnbaum BK, Byrne P, Brauth JB, Katholi M, Kim MY, Fischer J, Clancy RM, Buyon JP (2000) Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. Ann Rheum Dis 68:828–835
Izmirly PM, Rivera TL, Buyon JP (2007) Neonatal lupus syndromes. Rheum Dis Clin N Am 33:267–285
Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA (2015) The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol 11:301–312
Ambrosi A, Sonesson SE, Wahren-Herlenius M (2014) Molecular mechanisms of congenital heart block. Exp Cell Res 325:2–9
Izmirly P, Saxena A, Buyon JP (2017) Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus. Curr Opin Rheumatol 29:467–472
Lee LA (1990) Maternal autoantibodies and pregnancy - II: the neonatal lupus syndrome. Baillieres Clin Rheumatol 4:69–84
Cimaz R, Spence DL, Hornberger L, Silverman ED (2003) Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 142:678–683
Kobayashi R, Mii S, Nakano T, Harada H, Eto H (2009) Neonatal lupus erythematosus in Japan: a review of the literature. Autoimmun Rev 8:462–466
Morel N, Georgin-Lavialle S, Levesque K, Guettrot-Imbert G, Le Guern V, Le Bidois J, Bessières B, Brouzes C, Le Mercier D, Villain E, Maltret A, Costedoat-Chalumeau N (2015) Lupus néonatal revue de la littérature. Rev Med Interne 36:159–166
Zuppa AA, Riccardi R, Frezza S, Gallini F, Luciano RM, Alighieri G, Romagnoli C, De Carolis S (2017) Neonatal lupus: follow-up in infants with anti-SSA/Ro antibodies and review of the literature. Autoimmun Rev 16:427–432
Weston WL, Morelli JG, Lee LA (1999) The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus. J Am Acad Dermatol 40:675–681
Neiman AR, Lee LA, Weston WL, Buyon JP (2000) Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 137:674–680
Silverman E, Jaeggi E (2010) Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol 72:223–225
Inzinger M, Salmhofer W, Binder B (2012) Neonatal lupus erythematosus and its clinical variability. J Dtsch Dermatol Ges 10:407–411
Hulsmann AR, Oranje AP (2014) Educational paper: neonatal skin lesions. Eur J Pediatr 173:557–566
Kaneko F, Tanji O, Hasegawa T, Ohto H, Yamazaki K (1992) Neonatal lupus erythematosus in Japan. J Am Acad Dermatol 26:397–403
Wisuthsarewong W, Soongswang J, Chantorn R (2011) Neonatal lupus erythematosus: clinical character, investigation, and outcome. Pediatr Dermatol 28:115–121
Li YQ, Wang Q, Luo Y, Zhao Y (2015) Neonatal lupus erythematosus: a review of 123 cases in China. Int J Rheum Dis 18:761–767
Chen CC, Lin KL, Chen CL, Wong AM, Huang JL (2013) Central nervous system manifestations of neonatal lupus: a systematic review. Lupus 22:1484–1488
Gordon PA (2007) Congenital heart block: clinical features and therapeutic approaches. Lupus 16:642–646
Martin TA (2014) Congenital heart block: current thoughts on management, morphologic spectrum, and role of intervention. Cardiol Young 24(Suppl 2):41–46
Saxena A, Izmirly PM, Mendez B, Buyon JP, Friedman DM (2014) Prevention and treatment in utero of autoimmune-associated congenital heart block. Cardiol Rev 22:263–267
Klein-Gitelman MS (2016) Neonatal lupus: what we have learned and current approaches to care. Curr Rheumatol Rep 18:60
Walling HW, Sontheimer RD (2009) Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 10:365–381
Izmirly PM, Saxena A, Sahl SK, Shah U, Friedman DM, Kim MY, Buyon JP (2016) Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system. Ann Rheum Dis 75:1161–1165
Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, Khamashta MA, Kim MY, Saxena A, Friedman D, Llanos C, Piette JC, Buyon JP (2012) Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 126:76–82
Epstein AE, JP DM, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Tracy CM, Epstein AE, Darbar D, JP DM, Dunbar SB, Estes NA 3rd, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines, Heart Rhythm Society (2013) (2012) ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 61:e6–e7
Hansson N, Oommen-Halbach A, Borkhardt A, Fangerau H (2017) Nobel prize nominees hundred years ago: Abraham Jacobi (1830-1919) and Otto Heubner (1843-1926). Eur J Pediatr 176:1411–1413
Acknowledgments
The authors thank the families for permitting to publish clinical images with recognizable features of their children.
The authors would like to thank Dr. Alec Villa for his assistance in the linguistic revision.
Funding
This work was supported in part by the Fondazione E. Balli and the Swiss Research Network of Clinical Pediatric Hubs.
Dr. Gregorio P. Milani is the current recipient of research grants from the Fondazione G. E D. de Marchi ONLUS.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and Animal Rights and Informed Consent
The present article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Vanoni, F., Lava, S.A.G., Fossali, E.F. et al. Neonatal Systemic Lupus Erythematosus Syndrome: a Comprehensive Review. Clinic Rev Allerg Immunol 53, 469–476 (2017). https://doi.org/10.1007/s12016-017-8653-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-017-8653-0